GE's contrast-enhanced spectral mammo goes to Beverly Hills

The Pink Lotus Breast Center, a breast center focused on the prevention, screening, diagnosis and treatment of breast cancer, has unveiled GE Healthcare's SenoBright, contrast-enhanced spectral mammography (CESM) technology at its flagship breast center in Beverly Hills, Calif.

CESM will be provided at the facility's Sheryl Crow Imaging Center.

When an inconclusive mammogram and ultrasound require further testing, scheduling and completing the next step, such as MRI, can create a lengthy path that may not even lead to a diagnosis, according to Pink Lotus, which added that CESM shortens this path for many patients in several ways, including:
  • A CESM exam only takes a little longer than a diagnostic mammogram, and uses the same equipment as a routine mammogram;
  • CESM technology isolates concerning lesions while hiding non-cancerous tissue;
  • Unlike MRI, CESM is not confounded by hormone replacement or menstrual cycles, so CESM can be scheduled immediately with results available within minutes; and
  • Compared with MRI, CESM does not cause as much discomfort or claustrophobia, and is four times faster.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.